ES534751A0 - Un procedimiento para preparar nuevos compuestos de cefem - Google Patents

Un procedimiento para preparar nuevos compuestos de cefem

Info

Publication number
ES534751A0
ES534751A0 ES534751A ES534751A ES534751A0 ES 534751 A0 ES534751 A0 ES 534751A0 ES 534751 A ES534751 A ES 534751A ES 534751 A ES534751 A ES 534751A ES 534751 A0 ES534751 A0 ES 534751A0
Authority
ES
Spain
Prior art keywords
procedure
preparing new
cefem compounds
new cefem
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES534751A
Other languages
English (en)
Other versions
ES8608526A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838320673A external-priority patent/GB8320673D0/en
Priority claimed from GB838330472A external-priority patent/GB8330472D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES534751A0 publication Critical patent/ES534751A0/es
Publication of ES8608526A1 publication Critical patent/ES8608526A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES534751A 1983-08-01 1984-07-31 Un procedimiento para preparar nuevos compuestos de cefem Expired ES8608526A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838320673A GB8320673D0 (en) 1983-08-01 1983-08-01 Cephem compounds
GB838330472A GB8330472D0 (en) 1983-11-15 1983-11-15 Cephem compounds

Publications (2)

Publication Number Publication Date
ES534751A0 true ES534751A0 (es) 1986-06-16
ES8608526A1 ES8608526A1 (es) 1986-06-16

Family

ID=26286725

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534751A Expired ES8608526A1 (es) 1983-08-01 1984-07-31 Un procedimiento para preparar nuevos compuestos de cefem

Country Status (10)

Country Link
US (2) US4871730A (es)
EP (2) EP0133678B1 (es)
JP (2) JPH0641473B2 (es)
AT (1) AT385758B (es)
CH (2) CH661733A5 (es)
DE (1) DE3483899D1 (es)
ES (1) ES8608526A1 (es)
FR (1) FR2550200B1 (es)
GB (1) GB2144420B (es)
IT (1) IT1183060B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550200B1 (fr) 1983-08-01 1988-04-08 Fujisawa Pharmaceutical Co Procede de preparation de composes de cephem a activite antimicrobienne et nouveaux produits ainsi obtenus
JPH0653739B2 (ja) * 1984-11-15 1994-07-20 協和醗酵工業株式会社 ３位置換カルバセフエム化合物
US4812562A (en) * 1985-07-25 1989-03-14 Taisho Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4699981A (en) * 1985-08-12 1987-10-13 Taisho Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4841044A (en) * 1985-12-23 1989-06-20 Taisho Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4937332A (en) * 1987-12-25 1990-06-26 Taisho Pharmaceutical Co., Ltd. Cephalosporin derivatives
DE69129065T2 (de) * 1990-08-09 1998-11-12 Sumitomo Electric Industries Thermoelement
WO1993013109A1 (en) * 1991-12-24 1993-07-08 Taisho Pharmaceutical Co., Ltd. Cephalosporin derivative
CA2123788C (en) * 1992-09-18 2001-03-13 Hiroshi Akagi Cephem compound, process for producing the compound, and pharmaceutical composition containing the same
AUPN801196A0 (en) * 1996-02-12 1996-03-07 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds and pharmaceutical use thereof
JP2002332288A (ja) * 1997-06-23 2002-11-22 Kyoto Pharmaceutical Industries Ltd セファロスポリン化合物、その用途およびその中間体化合物
US6159706A (en) * 1997-12-23 2000-12-12 Newbiotics, Inc. Application of enzyme prodrugs as anti-infective agents
JP4535530B2 (ja) * 1999-09-20 2010-09-01 大塚化学株式会社 ３−スルホニルオキシ−３−セフェム化合物の製造方法
WO2001083492A1 (en) * 2000-05-02 2001-11-08 Newbiotics, Inc. Improved beta-lactam antibiotics
US7687490B2 (en) * 2005-04-12 2010-03-30 Meiji Seika Kaisha, Ltd. 2-thioethenyl substituted carbapenem derivatives
EP3616695A1 (en) 2011-09-09 2020-03-04 Merck Sharp & Dohme Corp. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN103588791A (zh) * 2013-11-29 2014-02-19 中国科学院长春应用化学研究所 对硝基苄基-7-苯氧基乙酰胺-3-羟基头孢-4-羧酸酯-1-β-氧化物的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1425933A (en) * 1972-03-13 1976-02-25 Astra Laekemedel Ab Cephalosporins
GB1377624A (en) * 1972-07-07 1974-12-18 Glaxo Lab Ltd Cephalosporin compounds
CH605997A5 (es) * 1974-08-30 1978-10-13 Ciba Geigy Ag
US3992377A (en) * 1974-12-13 1976-11-16 Eli Lilly And Company 3-Thio-substituted cephalosporin antibiotics
ZA766941B (en) * 1975-11-21 1978-06-28 Merck & Co Inc 3-(substituted thio)cephalosporins,derivatives and nuclear analogues thereof
NL7708177A (nl) * 1976-07-29 1978-01-31 Hoechst Ag Werkwijze ter bereiding van cefemderivaten, als- mede farmaceutische preparaten die deze verbin- ding als actieve component bevatten.
JPS53103493A (en) * 1977-02-18 1978-09-08 Takeda Chem Ind Ltd Cephalosporin derivatives and process for their preparation
FR2418233A2 (fr) * 1978-02-22 1979-09-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkylthio ou 3-acylamino 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
EP0009008A3 (de) * 1978-09-08 1980-05-14 Ciba-Geigy Ag Cephalosporinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
US4390534A (en) * 1978-12-29 1983-06-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
US4291031A (en) * 1979-02-19 1981-09-22 Fujisawa Pharmaceutical Co., Ltd. 3-Phosphonocephalosporanic acid derivatives, and pharmaceutical composition comprising the same
GB2045233B (en) * 1979-03-23 1983-05-11 Erba Farmitalia Unsaturated 3-heterocyclylthiomethyl-7a-methoxy-7-acylamido-3-cephem-4-carboxylic acid derivatives
ZA805312B (en) * 1979-08-28 1981-08-26 Ciba Geigy Polyazathia compounds, processes for the manufacture thereof, pharmaceutical preparations containing such compounds and the use of the latter
US4281117A (en) * 1980-09-04 1981-07-28 Eli Lilly And Company Process for 3-chloro cephalosporin nucleus
GR76342B (es) * 1981-02-02 1984-08-06 Fujisawa Pharmaceutical Co
JPS5888386A (ja) * 1981-10-22 1983-05-26 Fujisawa Pharmaceut Co Ltd セフエム化合物およびその製造法
FR2550200B1 (fr) 1983-08-01 1988-04-08 Fujisawa Pharmaceutical Co Procede de preparation de composes de cephem a activite antimicrobienne et nouveaux produits ainsi obtenus
GB8329030D0 (en) * 1983-10-31 1983-11-30 Fujisawa Pharmaceutical Co Cephem compounds
EP0680094B1 (de) * 1994-04-29 2003-02-26 Shell Solar GmbH Netzunabhängiger elektrischer Energieverbraucher mit zusätzlicher photovoltaischer Stromversorgung

Also Published As

Publication number Publication date
GB2144420B (en) 1987-12-09
US4871730A (en) 1989-10-03
EP0268307A2 (en) 1988-05-25
AT385758B (de) 1988-05-10
IT1183060B (it) 1987-10-05
JPH0543584A (ja) 1993-02-23
EP0133678A3 (en) 1986-03-19
FR2550200B1 (fr) 1988-04-08
US4985555A (en) 1991-01-15
DE3483899D1 (de) 1991-02-14
JPH0641473B2 (ja) 1994-06-01
GB8419190D0 (en) 1984-08-30
CH663790A5 (de) 1988-01-15
IT8422142A0 (it) 1984-07-31
CH661733A5 (de) 1987-08-14
ES8608526A1 (es) 1986-06-16
EP0133678B1 (en) 1991-01-09
EP0268307A3 (en) 1989-06-28
ATA243884A (de) 1987-10-15
GB2144420A (en) 1985-03-06
JPS60100585A (ja) 1985-06-04
EP0133678A2 (en) 1985-03-06
FR2550200A1 (fr) 1985-02-08

Similar Documents

Publication Publication Date Title
ES534751A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES554546A0 (es) Un procedimiento para preparar derivados de guanina
ES530916A0 (es) Un procedimiento para preparar derivados de pirimidina
ES534694A0 (es) Un procedimiento para preparar cefuroxima sodica
ES527790A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES537104A0 (es) Un procedimiento para preparar derivados de tiazina
ES537668A0 (es) Un procedimiento para preparar n-formil-3-fenoxi-1-azetidincarboxamidas
ES523195A0 (es) Un procedimiento para preparar alquil-glicosidos
ES535568A0 (es) Un procedimiento para preparar derivados de piridazinona
ES503134A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES531550A0 (es) Procedimiento para preparar un fenilaminobencoalcanol
ES537351A0 (es) Un procedimiento para la preparacion de compuestos de -lactama
ES523193A0 (es) Un procedimiento para preparar 3-fenoxi-1-azetidincarbo-xznmidas
ES536050A0 (es) Un procedimiento para preparar fenil-carbamatos sustituidos
ES540784A0 (es) Un procedimiento para preparar compuestos relacionados con espergualina
ES534170A0 (es) Un procedimiento para preparar 1-piridil-alquil-4-aril-piperazinas
ES505498A0 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES538072A0 (es) Un procedimiento para preparar un difenil-eter
ES529034A0 (es) Un metodo para preparar nuevos compuestos de benzoilurea
ES526177A0 (es) Un procedimiento para preparar derivados de pirimidona
ES553983A0 (es) Un procedimiento para preparar compuestos de piridobenzodiazepina
ES530855A0 (es) Un procedimiento para preparar derivados de benzotiazina
ES529478A0 (es) Un procedimiento para preparar derivados de mitomicina
ES546669A0 (es) Un procedimiento para preparar compuestos relacionados con histargina
ES529721A0 (es) Un procedimiento para preparar nuevas aroilimidazolonas

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980302